Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > Here’s What to Expect From Johnson & Johnson’s Next Earnings Report
Economy

Here’s What to Expect From Johnson & Johnson’s Next Earnings Report

Last updated: June 28, 2025 4:00 am
Share
Here’s What to Expect From Johnson & Johnson’s Next Earnings Report
SHARE

Johnson & Johnson (JNJ) is a leading healthcare company headquartered in New Brunswick, New Jersey. The company is known for its research and development, manufacturing, and sale of various healthcare products worldwide. With a market capitalization of $366.4 billion, Johnson & Johnson operates through its Innovative Medicine and MedTech segments.

The company is gearing up to announce its second-quarter results on Wednesday, July 16. Analysts are projecting a non-GAAP earnings of $2.65 per share, a 6% decrease from the previous year. Despite the anticipated decline, Johnson & Johnson has consistently exceeded analysts’ expectations in recent quarters. For the full fiscal year 2025, earnings are expected to reach $10.60 per share, representing a 6.2% increase from the previous year. In fiscal 2026, earnings are projected to rise by 3.6% year-over-year to $10.98 per share.

Over the past 52 weeks, JNJ stock has shown a 3.5% growth, outperforming the Health Care Select Sector SPDR Fund’s 8.1% decline but falling short of the S&P 500 Index’s 12.1% increase during the same period. Despite delivering better-than-expected financial results in the first quarter, Johnson & Johnson’s stock experienced a slight dip initially. However, the company’s solid growth in US sales led to a 2.4% year-over-year increase in overall revenue to $21.9 billion. Additionally, adjusted earnings per share rose by 2.2% to $2.77, exceeding consensus estimates.

Analysts have a cautiously optimistic outlook on JNJ, with a “Moderate Buy” rating overall. Of the 23 analysts covering the stock, nine rate it as a “Strong Buy,” two as a “Moderate Buy,” and 12 as a “Hold.” The mean price target of $169.14 suggests an 11.3% upside potential from the current price levels.

See also  Is There Thimerosal in Vaccines, And Is It Safe? Here's What The Science Says : ScienceAlert

In conclusion, Johnson & Johnson continues to demonstrate resilience and growth in the healthcare industry. Investors are eagerly awaiting the company’s upcoming earnings report to gain further insights into its financial performance and future outlook. This article was originally published on Barchart.com and is intended for informational purposes only.

TAGGED:EarningsExpectHeresJohnsonJohnsonsreport
Share This Article
Twitter Email Copy Link Print
Previous Article Creating Bird Flu Vaccines for Humans at a Biosecure Laboratory Creating Bird Flu Vaccines for Humans at a Biosecure Laboratory
Next Article Summer 2025 Hot Shots … June Gloom?! More Like June Bloom! Summer 2025 Hot Shots … June Gloom?! More Like June Bloom!
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

This Ancient Herb Is Trending For Health Benefits, But Beware The Risks : ScienceAlert

Ashwagandha: The Herb Trending for its Health Benefits In recent times, the herb ashwagandha has…

April 26, 2025

Colbert Tells Trump ‘Go F— Yourself’ After President Exults Over ‘Late Show’ Cancellation

They have been very supportive of the show and of me, and I'm very grateful…

July 21, 2025

India’s MobiKwik surges 82% in market debut

Shares Surge as MobiKwik Makes Market Debut Shares in digital payments firm MobiKwik soared by…

December 17, 2024

Gaumont USA Sets Up Projects With Kate del Castillo, Karla Souza, Mariano Cohn and Gaston Duprat (EXCLUSIVE)  

Gaumont USA Expands Slate with New Titles Featuring Top Stars Gaumont USA, the Los Angeles…

September 29, 2025

May 12, tens of thousands die in Sichuan earthquake

It is currently Monday, May 12, 2025, marking the 132nd day of the year with…

May 12, 2025

You Might Also Like

Canada launches C.4bn minerals push as race to counter China heats up
Economy

Canada launches C$6.4bn minerals push as race to counter China heats up

October 31, 2025
Is Wall Street Bullish or Bearish on Freeport-McMoRan Stock?
Economy

Is Wall Street Bullish or Bearish on Freeport-McMoRan Stock?

October 31, 2025
Verizon Communications Stock: Analyst Estimates & Ratings
Economy

Verizon Communications Stock: Analyst Estimates & Ratings

October 31, 2025
BTIG Remains Positive on NextEra Energy (NEE), Highlighting its “Premier Generation Development Platform”
Economy

BTIG Remains Positive on NextEra Energy (NEE), Highlighting its “Premier Generation Development Platform”

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?